A simplified cloning strategy for the generation of an endothelial cell selective recombinant adenovirus vector

Journal of Virological Methods

Volumn 135, Issue 1, 2006, Pages 127-135

  Mahanivong, Chitladda ^a   Krüger, Jörg A ^a   Bian, Dafang ^a   Reisfeld, Ralph A ^a   Huang, Shuang ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adenovirus vector; Endothelium; Fiber; Re targeting; Recombination

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR;

ADENOVIRUS; AMINO ACID SEQUENCE; ARTICLE; ENDOTHELIUM CELL; GENE TARGETING; GENETIC TRANSDUCTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS FIBER; VIRUS RECOMBINANT;

ADENOVIRIDAE; CAPSID PROTEINS; CELL LINE; CLONING, MOLECULAR; ENDOTHELIAL CELLS; GENES, REPORTER; GENETIC VECTORS; HUMANS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 33646584514     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.02.010     Document Type: Article

References (45)

1. Arap W., Pasqualini R., and Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (1998) 377-380
2. Barnett B.G., Crews C.J., and Douglas J.T. Targeted adenoviral vectors. Biochim. Biophys. Acta 1575 (2002) 1-14
3. Belousova N., Krendelchtchikova V., Curiel D.T., and Krasnykh V. Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J. Virol. 76 (2002) 8621-8631
4. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., and Finberg R.W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
5. Bergers G., and Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 9 (2003) 661-668
6. Bett A.J., Prevec L., and Graham F.L. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67 (1993) 5911-5921
7. Bewley M.C., Springer K., Zhang Y.B., Freimuth P., and Flanagan J.M. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor. Science 286 (1999) 1579-1583
8. Bubeck P., Winkler M., and Bautsch W. Rapid cloning by homologous recombination in vivo. Nucleic Acids Res. 21 (1993) 3601-3602
9. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
10. Chartier C., Degryse E., Gantzer M., Dieterlé A., Pavirani A., and Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70 (1996) 4805-4810
11. Cleaver O.M.D.A. Endothelial signaling during development. Nat. Med. 9 (2003) 661-668
12. Dmitriev I., Krasnykh V., Miller C.R., Wang M., Kashentseva E., Mikheeva G., Belousova N., and Curiel D.T. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72 (1998) 9706-9713
13. Einfeld D.A., and Roelvink P.W. Advances towards targetable adenovirus vectors for gene therapy. Curr. Opin. Mol. Ther. 4 (2002) 444-451
14. El-Sheikh A., Liu C., Huang H., and Edgington T.S. A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium. Cancer Res. 62 (2002) 7118-7123
15. Everts M., and Curiel D.T. Transductional targeting of adenoviral cancer gene therapy. Curr. Gene Ther. 4 (2004) 337-346
16. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
17. Gall J., Kass-Eisler A., Leinwand L., and Falck-Pedersen E. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 70 (1996) 2116-2123
18. Green M., and Pina M. Biochemical studies on adenovirus multiplication. VI. Properties of highly purified tumorigenic human adenoviruses and their DNA's. Proc. Natl. Acad. Sci. U.S.A. 51 (1964) 1251-1259
19. Havenga M.J., Lemckert A.A., Grimbergen J.M., Vogels R., Huisman L.G., Valerio D., Bout A., and Quax P.H. Improved adenovirus vectors for infection of cardiovascular tissues. J. Virol. 75 (2001) 3335-3342
20. Jakubczak J.L., Rollence M.L., Stewart D.A., Jafari J.D., Von Seggern D.J., Nemerow G.R., Stevenson S.C., and Hallenbeck P.L. Adenovirus Type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells. J. Virol. 75 (2001) 2972-2981
21. Koivunen E., Wang B., and Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Nat. Biotechnol. 13 (1995) 265-270
22. Koizumi N., Mizuguchi H., Hosono T., Ishii-Watabe A., Uchida E., Utoguchi N., Watanabe Y., and Hayakawa T. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim. Biophys. Acta 1568 (2001) 13-20
23. Kovesdi I., Brough D.E., Bruder J.T., and Wickham T.J. Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol. 8 (1997) 583-589
24. Krasnykh V., Dmitriev I., Mikheeva G., Miller C.R., Belousova N., and Curiel D.T. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72 (1998) 1844-1852
25. Kupprion C., Motamed K., and Sage E.H. SPARC (BM-40, Osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273 (1998) 29635-29640
26. Liu Q., and Muruve D.A. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10 (2003) 935-940
27. McConnell M.J., and Imperiale M.J. Biology of Adenovirus and its use as a vector for gene therapy. Hum. Gene Ther. 15 (2004) 1022-1033
28. Michael S.I., Hong J.S., Curiel D.T., and Engler J.A. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2 (1995) 660-668
29. Mizuguchi H., and Hayakawa T. Targeted adenovirus vectors. Hum. Gene Ther. 15 (2004) 1034-1044
30. Mizuguchi H., Koizumi N., Hosono T., Utoguchi N., Watanabe Y., Kay M.A., and Hayakawa T. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 8 (2001) 730-735
31. Nicklin S.A., Von Seggern D.J., Work L.M., Pek D.C.K., Dominiczak A.F., Nemerow G.R., and Baker A.H. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generates an endothelial cell-selective adenovirus. Mol. Ther. 4 (2001) 534-542
32. Nicklin S.A., White S.J., Nicol C.G., Von Seggern D.J., and Baker A.H. In vitro and in vivo characterization of endothelial cell selective adenoviral vectors. J. Gene Med. 6 (2004) 300-308
33. Nicklin S.A., White S.J., Watkins S.J., Hawkins R.E., and Baker A.H. Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation 102 (2000) 231-237
34. Niethammer A.G., Xiang R., Becker J.C., Wodrich H., Pertl U., Karsten G., Eliceiri B.P., and Reisfeld R.A. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat. Med. 8 (2002) 1369-1375
35. Pasqualini R., Koivunen E., and Ruoslahti E. αv integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15 (1997) 542-546
36. Rein D.T., Breidenbach M., Wu H., Han T., Haviv Y.S., Wang M., Kirby T.O., Kawakami Y., Dall P., Alvarez R.D., and Curiel D.T. Gene transfer to cervical cancer with fiber-modified adenoviruses. Int. J. Cancer 111 (2004) 698-704
37. Roelvink P.W., Lee G.M., Einfeld D.A., Kovesdi I., and Wickham T.J. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286 (1999) 1568-1571
38. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12 (1996) 697-715
39. Russell W.C. Update on adenovirus and its vectors. J. Gen. Virol. 81 (2000) 2573-2604
40. Shayakhmetov D.M., Papayannopoulou T., Stamatoyannopoulos G., and Lieber A. Efficient gene transfer into human CD34+ cells by a retargeted adenovirus vector. J. Virol. 74 (2000) 2567-2584
41. Stevenson S.C., Rollence M., Marshall-Neff J., and McClelland A. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 71 (1997) 4782-4790
42. Von Seggern D.J., Kehler J., Endo R., and Nemerow G.R. Complementation of a fiber mutant adenovirus by packaging cell lines stably expressing the Ad5 fiber protein. J. Gen. Virol. 79 (1998) 1461-1468
43. Wickham T.J., Roelvink P.W., Brough D.E., and Kovesdi I. Adenovirus targeted to heparin-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14 (1996) 1570-1573
44. Xia D., Henry L.J., Gerard R.D., and Deisenhofer J. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 Å resolution. Structure 2 (1994) 1259-1270
45. Xiang R., Mizutani N., Luo Y., Chiodoni C., Zhou H., Mizutani M., Ba Y., Becker J.C., and Reisfeld R.A. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res. 65 (2005) 553-561